Market Overview

After Hitting Support, Vetr Issues Buy Rating On Bristol Myers

Share:

The Vetr crowd on Wednesday upgraded its rating on Bristol-Myers Squibb Company (NYSE: BMY) from 3 stars (Hold), issued 12 days ago, to 3.5 stars (Buy). Crowd sentiment at the time of the upgrade was mostly positive, with 80 percent of Vetr user ratings bullish.

Shares price in the biotech comapny has remained in range for the better part of Q4, finding recent support around the $61 area. The stock reached that floor again Wednesday for the third time in the past month and finished the day at $61.20

See how crowdsourced ratings could help you time the market.

Currently, the Vetr crowd's average price target on Bristol-Myers is up at $64.91, which is higher than the average analyst price target of $62.35. Less than 2 percent of Vetr users are holding BMY in their watch-lists.

Posted-In: VetrUpgrades Price Target Crowdsourcing Analyst Ratings General

 

Related Articles (BMY)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
SKXMaintains44.0
HYMaintains66.0
MSFTMaintains160.0
SKXUpgrades
WLTWMaintains208.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

KeyBanc's Guide To REITs In 2018: Expect 5-10% Returns

5 Stocks Moving In Wednesday's After-Hours Session